Monday, April 15, 2024 12:59:39 PM
They ask you to believe:
1. At the same time NWBO knew it had not even selected the prototype for Eden,
2. They submitted a marketing approval (150 day) request for DCVax-l
3. That they only wanted to take 80 days for review prior to either an RFI or MHRA determination period.
4. But really, they planned on day 45, to spring a request to change the approval request to be based upon Eden manufacturing instead of artisan,
5. When Eden had “several” more months before gmp compliant units could be manufactured and “qualified” plus several more months before it could be validated and engineering runs could finally be submitted to regulators for yet more months of MHRA determination.
6. It would be absolutely inane to request a 150 day DCVax-l marketing approval process to be based on a manufacturing process you hadn’t even selected a prototype for, let alone only selecting which prototype at day 45 of the 80 day review period. Imo.
Instead, NWBO has been meticulously planning to start commercialization with the artisan manufacturing process that was ready and expanded to meet over 90 patients a month upon commercial approval of DCVax-l. After which, at some point when Eden passed muster, they could transition to Eden to meet a much larger market.
Duh.
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM